Stay updated on Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.

Latest updates to the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page
- Check7 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new terminology related to advanced cutaneous squamous cell carcinoma and the revision of the study version from v2.14.4 to v2.15.0. Notably, the names of collaborators and investigators have been retained, indicating continuity in the study's leadership.SummaryDifference19%
- Check14 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has been changed from March 25, 2025, to January 27, 2025.SummaryDifference0.4%
- Check22 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of January 27, 2025, and version 2.14.2.SummaryDifference0.3%
- Check29 days agoNo Change Detected
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check65 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check79 days agoChange DetectedThe website has added a new entry for Moran Mishal, MD, and updated the revision to v2.14.2, while removing the entry for Sumera Raoof, MD, and reverting the revision from v2.14.1.SummaryDifference1%
Stay in the know with updates to Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.